| Osteogenesis imperfecta: mechanisms and signaling pathways connecting classical and rare OI types M Jovanovic, G Guterman-Ram, JC Marini Endocrine reviews 43 (1), 61-90, 2022 | 83 | 2022 |
| Perturbed bone composition and integrity with disorganized osteoblast function in zinc receptor/Gpr39‐deficient mice M Jovanovic, FN Schmidt, G Guterman‐Ram, H Khayyeri, S Hiram‐Bab, ... The FASEB Journal 32 (5), 2507-2518, 2018 | 19 | 2018 |
| Specific inflammatory osteoclast precursors induced during chronic inflammation give rise to highly active osteoclasts associated with inflammatory bone loss Y Meirow, M Jovanovic, Y Zur, J Habib, DF Colombo, N Twaik, ... Bone research 10 (1), 36, 2022 | 18 | 2022 |
| SMAD3 mutation in LDS3 causes bone fragility by impairing the TGF-β pathway and enhancing osteoclastogenesis A El-Gazzar, H Kang, N Fratzl-Zelman, E Webb, AM Barnes, M Jovanovic, ... Bone Reports 17, 101603, 2022 | 5 | 2022 |
| Dual‐specificity tyrosine phosphorylation‐regulated kinase 2 regulates osteoclast fusion in a cell heterotypic manner G Guterman‐Ram, M Pesic, A Orenbuch, T Czeiger, A Aflalo, N Levaot Journal of cellular physiology 233 (1), 617-629, 2018 | 5 | 2018 |
| CaMKII inhibition due to TRIC-B loss-of-function dysregulates SMAD signaling in osteogenesis imperfecta R Besio, BM Contento, N Garibaldi, M Filibian, S Sonntag, D Shmerling, ... Matrix Biology 120, 43-59, 2023 | 1 | 2023 |
| Absence of TRIC-B from type XIV Osteogenesis Imperfecta osteoblasts alters cell adhesion and mitochondrial function–A multi-omics study M Jovanovic, A Mitra, R Besio, BM Contento, KW Wong, A Derkyi, M To, ... Matrix Biology 121, 127-148, 2023 | | 2023 |
| The role of TMEM38B in OI osteoblasts differentiation and mineralization M Jovanovic, A Mitra, RK Dale, JC Marini Bone Reports 16, 101509, 2022 | | 2022 |
| Study of OI patient osteoblasts to investigate phenotypic variability of dominant osteogenesis imperfecta M Jovanovic, A Mitra, R Dale, J Marini EUROPEAN JOURNAL OF HUMAN GENETICS 30 (SUPPL 1), 174-174, 2022 | | 2022 |
| Studies of OI Patient and Murine Osteoblasts to Investigate Phenotypic Variability of Dominant Osteogenesis Imperfecta M Jovanovic, A Mitra, C Stephan, K Kozloff, R Dale, J Marini JOURNAL OF BONE AND MINERAL RESEARCH 37, 171-171, 2022 | | 2022 |
| Studies of OI patient and murine osteoblasts to investigate phenotypic variability of dominant Osteogenesis Imperfecta M Jovanovic, A Mitra, C Stephan, K Kozloff, R Dale, JC Marini Bone Reports 14, 100863, 2021 | | 2021 |
| Studies of OI Patient and Murine Osteoblasts to Investigate Phenotypic Variability of Dominant Osteogenesis Imperfecta M Jovanovic, A Mitra, RK Dale, JC Marini JOURNAL OF BONE AND MINERAL RESEARCH 35, 307-307, 2020 | | 2020 |
| GPR39 is negatively regulating osteoblast differentiation and bone formation during aging M Pesic, GG Ram, A Orenbuch, S Katchkovsky, N Levaot Bone Abstracts 5, 2016 | | 2016 |
Joan MariniSenior Investigator, NICHD, NIHVerified email at cc1.nichd.nih.gov
